文献速递运动医学

肌肉前体细胞促进大鼠肌肉损伤功能恢复并与伤后跑步机运动协同

Muscle Precursor Cells Enhance Functional Muscle Recovery and Show Synergistic Effects With Postinjury Treadmill Exercise in a Muscle Injury Model in Rats.
PubMed 文献 · Am J Sports Med · 2021-01-01

该研究在大鼠骨骼肌损伤模型中评估肌肉前体细胞(MPC)移植单独或联合为期2周每日跑步机运动的效果。结果显示,MPC移植显著改善肌肉力量恢复、促进再生肌纤维生长并减少纤维化,联合运动未见额外获益但呈现协同趋势。

要点

  • 单次超声引导下注射MPC可显著改善损伤肌肉的力量恢复。
  • MPC移植促进再生肌纤维横截面积增大并减少I型胶原沉积。
  • MPC联合伤后早期主动运动在大鼠中显示协同效应。

核心结论

  • 单次肌内注射MPC可改善大鼠损伤骨骼肌的组织学结局和力量恢复。
  • 细胞治疗联合早期主动康复方案在大鼠中显示出协同效应,提示联合治疗可能成为人类骨骼肌损伤的新策略。

研究设计与样本

  • controlled laboratory study,共使用27只大鼠,其中3只用于分离MPC,24只诱导骨骼肌损伤并分为3组。
  • 损伤后36小时,动物接受单次超声引导下MPC(10^5细胞)注射(Cells组)、MPC注射联合2周每日运动训练(Cells+Exercise组)或肌内载体注射(Vehicle组)。
  • 损伤后2周测定肌肉力量,并收集肌肉进行组织学和免疫荧光评估。

主要发现

  • 红色荧光标记的MPC成功移植到损伤部位,2周后定位于损伤区域,并与发育型肌球蛋白重链(dMHC)阳性肌纤维共定位。
  • Cells组和Cells+Exercise组的最大强直力分别为损伤侧与健康对侧肌肉的102.6%±4.0%和101.5%±8.5%,Vehicle组为78.2%±5.1%。
  • Cells组和Cells+Exercise组的肌纤维横截面积分别为612.3±21.4 µm²和686.0±11.6 µm²,Vehicle组为247.5±10.7 µm²。
  • Cells组和Cells+Exercise组的I型胶原沉积分别为24.2%±1.3%和26.0%±1.9%,Vehicle组为40.9%±4.1%。
  • Cells组和Cells+Exercise组的dMHC阳性再生肌纤维比例分别为4.3%±2.6%和4.1%±1.5%,Vehicle组为14.8%±13.9%。

临床怎么用

  • MPC移植可能作为促进骨骼肌损伤后力量恢复和再生、减少纤维化的治疗策略。
  • 细胞治疗联合伤后早期主动康复方案可能产生协同效应,支持开展运动员MPC移植联合康复方案的临床试验。

局限性

  • 研究为大鼠小动物模型,样本量有限(共27只大鼠),结果向人类临床转化需进一步验证。
  • 研究未报告长期随访、安全性数据或临床结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Skeletal muscle injuries represent a major concern in sports medicine. Cell therapy has emerged as a promising therapeutic strategy for muscle injuries, although the preclinical data are still inconclusive and the potential clinical use of cell therapy has not yet been established. PURPOSE: To evaluate the effects of muscle precursor cells (MPCs) on muscle healing in a small animal model. STUDY DESIGN: Controlled laboratory study. METHODS: A total of 27 rats were used in the study. MPCs were isolated from rat (n = 3) medial gastrocnemius muscles and expanded in primary culture. Skeletal muscle injury was induced in 24 rats, and the animals were assigned to 3 groups. At 36 hours after injury, animals received treatment based on a single ultrasound-guided MPC (105 cells) injection (Cells group) or MPC injection in combination with 2 weeks of daily exercise training (Cells+Exercise group). Animals receiving intramuscular vehicle injection were used as controls (Vehicle group). Muscle force was determined 2 weeks after muscle injury, and muscles were collected for histological and immunofluorescence evaluation. RESULTS: Red fluorescence-labeled MPCs were successfully transplanted in the site of the injury by ultrasound-guided injection and were localized in the injured area after 2 weeks. Transplanted MPCs participated in the formation of regenerating muscle fibers as corroborated by the co-localization of red fluorescence with developmental myosin heavy chain (dMHC)-positive myofibers by immunofluorescence analysis. A strong beneficial effect on muscle force recovery was detected in the Cells and Cells+Exercise groups (102.6% ± 4.0% and 101.5% ± 8.5% of maximum tetanus force of the injured vs healthy contralateral muscle, respectively) compared with the Vehicle group (78.2% ± 5.1%). Both Cells and Cells+Exercise treatments stimulated the growth of newly formed regenerating muscles fibers, as determined by the increase in myofiber cross-sectional area (612.3 ± 21.4 µm2 and 686.0 ± 11.6 µm2, respectively) compared with the Vehicle group (247.5 ± 10.7 µm2), which was accompanied by a significant reduction of intramuscular fibrosis in Cells and Cells+Exercise treated animals (24.2% ± 1.3% and 26.0% ± 1.9% of collagen type I deposition, respectively) with respect to control animals (40.9% ± 4.1% in the Vehicle group). MPC treatment induced a robust acceleration of the muscle healing process as demonstrated by the decreased number of dMHC-positive regenerating myofibers (enhanced replacement of developmental myosin isoform by mature myosin isoforms) (4.3% ± 2.6% and 4.1% ± 1.5% in the Cells and Cells+Exercise groups, respectively) compared with the Vehicle group (14.8% ± 13.9%). CONCLUSION: Single intramuscular administration of MPCs improved histological outcome and force recovery of the injured skeletal muscle in a rat injury model that imitates sports-related muscle injuries. Cell therapy showed a synergistic effect when combined with an early active rehabilitation protocol in rats, which suggests that a combination of treatments can generate novel therapeutic strategies for the treatment of human skeletal muscle injuries. CLINICAL RELEVANCE: Our study demonstrates the strong beneficial effect of MPC transplant and the synergistic effect when the cell therapy is combined with an early active rehabilitation protocol for muscle recovery in rats; this finding opens new avenues for the development of effective therapeutic strategies for muscle healing and clinical trials in athletes undergoing MPC transplant and rehabilitation protocols.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Contreras-Muñoz P, Torrella JR, Venegas V, et al. Muscle Precursor Cells Enhance Functional Muscle Recovery and Show Synergistic Effects With Postinjury Treadmill Exercise in a Muscle Injury Model in Rats. Am J Sports Med. 2021. PMID: 33719605. doi:10.1177/0363546521989235

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。